novel

Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of CancerOxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer

Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer

March 19, 2025 04:00 ET  | Source: Oxford BioTherapeutics Collaboration leverages OBT’s proprietary OGAP®-Verify discovery platform and Roche’s drug development…

2 weeks ago
Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back PainPersica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain

Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain

Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic…

1 month ago
Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial Hypertension (IIH)Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial Hypertension (IIH)

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial Hypertension (IIH)

HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company dedicated to the treatment…

1 month ago
Prajakta Koli’s debut novel, Too Good To Be True, becomes a publishing sensation with 1,50,000 copies sold within a month of its releasePrajakta Koli’s debut novel, Too Good To Be True, becomes a publishing sensation with 1,50,000 copies sold within a month of its release

Prajakta Koli’s debut novel, Too Good To Be True, becomes a publishing sensation with 1,50,000 copies sold within a month of its release

NEW DELHI, Feb. 13, 2025 /PRNewswire/ -- Breathing new life into Indian romance writing while bringing hordes of young Indians…

2 months ago
ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

MELBOURNE, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers…

2 months ago
Ye Xiu Joins Global Fans in Singapore to Ring in New Year’s Eve, Yuewen Music Festival Pioneers Novel IP Experiences and ScenariosYe Xiu Joins Global Fans in Singapore to Ring in New Year’s Eve, Yuewen Music Festival Pioneers Novel IP Experiences and Scenarios

Ye Xiu Joins Global Fans in Singapore to Ring in New Year’s Eve, Yuewen Music Festival Pioneers Novel IP Experiences and Scenarios

Singapore, Jan. 07, 2025 (GLOBE NEWSWIRE) -- As the clock ticked down the last few hours of 2024, Sentosa Beach…

3 months ago
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol SubstituteClearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada,…

3 months ago
Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibioticsBasilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Additional funding awarded following successful drug candidate nominationUSD 7.3 million to support progression of antibiotic BAL2420 (LptA inhibitor) towards first-in-human…

3 months ago
HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great startHarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

HarperCollins India is thrilled to share that Prajakta Koli’s novel, Too Good To Be True, is now on preorder and off to a great start

Prajakta Koli's debut romance novel, Too Good to Be True,is making waves within a few hours of its pre-order going…

4 months ago
Show more Posts